Ashoka Fellow
Fellow Since 2014
This description of Caroline Kant's work was prepared when Caroline Kant was elected to the Ashoka Fellowship in 2014.
Caroline has created a new way forward for existing drugs to be developed in rare diseases, ultimately bring treatments to these underserved patients at an affordable cost. She is accelerating the cost-effective development of unexplored therapeutic opportunities in rare diseases by addressing key translational gaps and clinical development challenges, acting as an investor, a patient voice integrator and a trusted broker between patients, pharmaceutical companies biomedical centers of expertise and regulatory authorities.
The New Idea
The Problem
The Strategy
The Person

More For You